The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
Open accessAbstract
Agonists of the nuclear receptor PPARγ are therapeutically used to combat hyperglycaemia associated with the metabolic syndrome and type 2 diabetes. In spite of being effective in normalization of blood glucose levels, the currently used PPARγ agonists from the thiazolidinedione type have serious side effects, making the discovery of novel ligands highly relevant. Natural products have proven historically to be a promising pool of structures for drug discovery, and a significant research effort has recently been undertaken to explore the PPARγ-activating potential of a wide range of natural products originating from traditionally used medicinal plants or dietary sources. The majority of identified compounds are selective PPARγ modulators (SPPARMs), transactivating the expression of PPARγ-dependent reporter genes as partial agonists. Those natural PPARγ ligands have different binding modes to the receptor in comparison to the full thiazolidinedione agonists, and on some occasions activate in addition PPARα (e.g. genistein, biochanin A, sargaquinoic acid, sargahydroquinoic acid, resveratrol, amorphastilbol) or the PPARγ-dimer partner retinoid X receptor (RXR; e.g. the neolignans magnolol and honokiol). A number of in vivo studies suggest that some of the natural product activators of PPARγ (e.g. honokiol, amorfrutin 1, amorfrutin B, amorphastilbol) improve metabolic parameters in diabetic animal models, partly with reduced side effects in comparison to full thiazolidinedione agonists. The bioactivity pattern as well as the dietary use of several of the identified active compounds and plant extracts warrants future research regarding their therapeutic potential and the possibility to modulate PPARγ activation by dietary interventions or food supplements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–236 of 236
Pharmacophore-driven identification of PPARγ agonists from natural sources
Petersen, R. K., Christensen, K. B., Assimopoulou, A. N., Fretté, X. C., Papageorgiou, V. P., Kristiansen, K., & Kouskoumvekaki, I. A. (2010) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-010-9398-5 · Cited by 60
Sakuranetin induces adipogenesis of 3T3-L1 cells through enhanced expression of PPARγ2
Saito, T., Abe, D., & Sekiya, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.146 · Cited by 59
Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARγ
Ge, H., Zhang, J., Guo, B.-S., He, Q., Wang, B., He, B., & Wang, C. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.08.412 · Cited by 58
Culinary plants, herbs and spices – A rich source of PPARγ ligands
Mueller, M., & Jungbauer, A. (2009) · Food Chemistry · doi:10.1016/j.foodchem.2009.04.063 · Cited by 58
Si, S. (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000398 · Cited by 57
Guasch, L., Sala, E., Valls, C., Blay, M., Mulero, M., Arola, L., Pujadas, G., & García-Vallvé, S. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9446-9 · Cited by 55
Rupp, M., Schroeter, T. S., Steri, R., Zettl, H., Proschak, E., Hansen, K., Rau, O., Schwarz, O., Müller‐Kuhrt, L., Schubert‐Zsilavecz, M., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200900469 · Cited by 54
Mueller, M., Hobiger, S., & Jungbauer, A. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181c94617 · Cited by 52
Dong, W., Wang, X., Bi, S., Pan, Z., Liu, S.-X., Yu, H., LU, H., Lin, X., WANG, X., MA, T., et al. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1680 · Cited by 51
Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist
Goto, T., Nagai, H., Egawa, K., Kim, Y., Kato, S., Taimatsu, A., Sakamoto, T., Ebisu, S., Hohsaka, T., Miyagawa, H., et al. (2011) · Biochemical Journal · doi:10.1042/bj20101939 · Cited by 51
Mora, F. D., Jones, D. K., Desai, P. V., Patny, A., Avery, M. A., Feller, D. R., Smillie, T. J., Zhou, Y., & Nagle, D. G. (2006) · Journal of Natural Products · doi:10.1021/np050397q · Cited by 48
Ouarghidi, A., Martin, G. J., Powell, B., et al. (2013) · Journal of Ethnobiology and Ethnomedicine · doi:10.1186/1746-4269-9-59 · Cited by 48
Chung, S. W., Kim, M. K., Chung, J. H., Kim, D. H., Choi, J. S., Anton, S. D., Seo, A. Y., Park, K.-Y., Yokozawa, T., Rhee, S., et al. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2007.0660 · Cited by 45
Dual Acting and Pan-PPAR Activators as Potential Anti-diabetic Therapies
Heald, M., & Cawthorne, M. A. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_2 · Cited by 43
Vogl, S., Atanasov, A. G., Binder, M., Bulusu, M. A. R. C., Zehl, M., Fakhrudin, N., Heiß, E. H., Picker, P., Wawrosch, C., Saukel, J., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/395316 · Cited by 41
Self-citationEmerging roles of PPARδ in metabolism
Seedorf, U., & Aberle, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.04.017 · Cited by 41
Lewis, S. N., Brannan, L., Guri, A. J., Lu, P., Hontecillas, R., Bassaganya-Riera, J., & Bevan, D. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024031 · Cited by 41
Do, Q., Lamy, C., Renimel, I., et al. (2007) · Planta Medica · doi:10.1055/s-2007-990216 · Cited by 39
Honokiol Increases ABCA1 Expression Level by Activating Retinoid X Receptor Beta
Jung, C., Horike, H., Cha, B., Uhm, K., Yamauchi, R., Yamaguchi, T., Hosono, T., Iida, K., Woo, J., & Michikawa, M. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1105 · Cited by 39
Kotani, H., Tanabe, H., Mizukami, H., Amagaya, S., & Inoue, M. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.1 · Cited by 36
Activation of PPARγ by Metabolites from the Flowers of Purple Coneflower (Echinacea purpurea)
Christensen, K. B., Petersen, R. K., Petersen, S., Kristiansen, K., & Christensen, L. P. (2009) · Journal of Natural Products · doi:10.1021/np900003a · Cited by 35
Bhalla, K., Hwang, B. J., Choi, J. H., Dewi, R. E., Ou, L., McLenithan, J. C., Twaddel, W., Pozharski, E. V., Stock, J. B., & Girnun, G. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257915 · Cited by 32
Structure‐Based Pharmacophore Screening for Natural‐Product‐Derived PPARγ Agonists
Tanrikulu, Y., Rau, O., Schwarz, O., Proschak, E., Siems, K., Müller‐Kuhrt, L., Schubert‐Zsilavecz, M., & Schneider, G. (2008) · ChemBioChem · doi:10.1002/cbic.200800520 · Cited by 30
Total synthesis and dual PPARα/γ agonist effects of Amorphastilbol and its synthetic derivatives
Kim, T., Lee, W., Jeong, K. H., Song, J. H., Park, S.-H., Choi, P., Kim, S., Lee, S., & Ham, J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.062 · Cited by 29
Rozema, E., Atanasov, A. G., Fakhrudin, N., Singhuber, J., Namduang, U., Heiß, E. H., Reznicek, G., Huck, C. W., Bonn, G., Dirsch, V. M., et al. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/983023 · Cited by 28
Self-citation7-Chloroarctinone-b as a new selective PPARγ antagonist potently blocks adipocyte differentiation
Li, Y., Li, L., Chen, J., Hu, T., Huang, J. Y., Guo, Y., Jiang, H., & Shen, X. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.113 · Cited by 27
Mitogen-activated protein kinase phosphatase-1 – a potential therapeutic target in metabolic disease
Flach, R. J. R., & Bennett, A. M. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.528395 · Cited by 25
Geschichte einer Pflanze am Beispiel von Echinacea
Hostettmann, K. (2003) · Complementary Medicine Research · doi:10.1159/000071678 · Cited by 25
Cornick, C., Strongitharm, B. H., Sassano, G., Rawlins, C., Mayes, A. E., Joseph, A. N., O’Dowd, J. F., Stocker, C. J., Wargent, E. T., Cawthorne, M. A., et al. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.07.010 · Cited by 24
Yokoi, H., Mizukami, H., Nagatsu, A., Ohno, T., Tanabe, H., & Inoue, M. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.735 · Cited by 24
Anti-diabetic effect of amorphastilbol through PPARα/γ dual activation in db/db mice
Lee, W., Ham, J., Kwon, H. C., Kim, Y. K., & Kim, S. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.083 · Cited by 24
Liver X receptor and peroxisome proliferator-activated receptor agonist from Cornus alternifolia
He, Y., Ma, G., Peng, J., Ma, Z., & Hamann, M. T. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.02.004 · Cited by 15
Subramani, P. A., Reddy, M. C., & Narala, V. R. (2013) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/18715303113139990003 · Cited by 15
Nampoothiri, S. V., Raj, S., Prathapan, A., Abhilash, P. A., Arumughan, C., & Sundaresan, A. (2011) · Natural Product Research · doi:10.1080/14786419.2010.482053 · Cited by 14
Long-term Risk of Cardiovascular Events With Rosiglitazone: A Meta-analysis
Singh, S., Loke, Y. K., & Furberg, C. D. (2007) · JAMA · doi:10.1001/jama.298.10.1189 · Cited by 5
Virtanen (1998) · doi:10.1002/(sici)1096-9136(199809)15:9
Cited by
Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects
Zhang, H., & Tsao, R. (2016) · Current Opinion in Food Science · doi:10.1016/j.cofs.2016.02.002 · Cited by 1,519
An update on PPAR activation by cannabinoids
O'Sullivan, S. E. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13497 · Cited by 449
Natural Products for the Treatment of Type 2 Diabetes Mellitus
Ríos, J., Francini, F., & Schinella, G. (2015) · Planta Medica · doi:10.1055/s-0035-1546131 · Cited by 446
The Prevalence of Metabolic Syndrome in Children: A Systematic Review of the Literature
Friend, A., Craig, L., & Turner, S. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0122 · Cited by 354
Health benefits of dietary marine DHA/EPA-enriched glycerophospholipids
Zhang, T.-T., Xu, J., Wang, Y.-M., & Xue, C.-H. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.100997 · Cited by 339
Metadata
- Authors
- Wang, L., Waltenberger, B., Pferschy-Wenzig, E.-M., Blunder, M., Liu, X., Malainer, C., Blazevic, T., Schwaiger, S., Rollinger, J. M., Heiss, E. H., Schuster, D., Kopp, B., Bauer, R., Stuppner, H., Dirsch, V. M., & Atanasov, A. G.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 92
- Issue
- 1
- Pages
- 73-89
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2067942093
- Cited by
- 594
- References
- 236
- FWCI
- 18.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.